rs11248877
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001372107.1(UNKL):c.287+417T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.943 in 152,110 control chromosomes in the GnomAD database, including 67,706 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.94 ( 67706 hom., cov: 30)
Consequence
UNKL
NM_001372107.1 intron
NM_001372107.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.32
Publications
4 publications found
Genes affected
UNKL (HGNC:14184): (unk like zinc finger) This gene encodes a RING finger protein that may function in Rac signaling. It can bind to Brg/Brm-associated factor 60b and can promote its ubiquitination. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jun 2013]
UNKL Gene-Disease associations (from GenCC):
- Tourette syndromeInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.05).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| UNKL | NM_001372107.1 | c.287+417T>C | intron_variant | Intron 2 of 14 | ENST00000389221.9 | NP_001359036.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| UNKL | ENST00000389221.9 | c.287+417T>C | intron_variant | Intron 2 of 14 | 5 | NM_001372107.1 | ENSP00000373873.6 |
Frequencies
GnomAD3 genomes AF: 0.943 AC: 143330AN: 151992Hom.: 67645 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
143330
AN:
151992
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.943 AC: 143450AN: 152110Hom.: 67706 Cov.: 30 AF XY: 0.945 AC XY: 70283AN XY: 74370 show subpopulations
GnomAD4 genome
AF:
AC:
143450
AN:
152110
Hom.:
Cov.:
30
AF XY:
AC XY:
70283
AN XY:
74370
show subpopulations
African (AFR)
AF:
AC:
40250
AN:
41478
American (AMR)
AF:
AC:
14510
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
3200
AN:
3472
East Asian (EAS)
AF:
AC:
5167
AN:
5170
South Asian (SAS)
AF:
AC:
4627
AN:
4820
European-Finnish (FIN)
AF:
AC:
10004
AN:
10584
Middle Eastern (MID)
AF:
AC:
286
AN:
294
European-Non Finnish (NFE)
AF:
AC:
62514
AN:
68002
Other (OTH)
AF:
AC:
2025
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
402
804
1205
1607
2009
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3425
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.